Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Prothena moves forward with layoffs; Aldeyra resubmits dry eye drug to FDA
4 weeks ago
News Briefing
Mineralys gets a mid-stage win in hypertension patients with poor renal function
4 weeks ago
R&D
Dyne pivots on primary endpoint, delays filing for DM1 drug
4 weeks ago
R&D
Isomorphic to open US office in Cambridge, hires ex-Relay CMO
4 weeks ago
People
AI
Lilly to bolster gene editing pipeline, buying Verve for up to $1.3B
4 weeks ago
Deals
Immuneering says MEK pill beats standard of care in first-line pancreatic cancer
4 weeks ago
R&D
Fired vaccine advisors defend ACIP’s work, independence in joint editorial
4 weeks ago
R&D
Pharma
Purdue opioid settlement gets backing from 55 attorneys general
4 weeks ago
Pharma
Law
Eli Lilly makes all Zepbound doses available in single-dose vials
4 weeks ago
Pharma
Marketing
What's coming in five years? FDA chief points to universal flu vaccine, new approval pathway
4 weeks ago
FDA+
AbbVie’s cancer drug fails Phase 3 combo study to treat other bone marrow diseases
4 weeks ago
R&D
Pharma
Roche moves ahead with Phase 3 Parkinson’s study despite mixed trial results
4 weeks ago
R&D
Incyte’s promising thrombocythemia drug; Crescent Biopharma raises $200M in PIPE
4 weeks ago
News Briefing
NextCure inks ADC deal with Shanghai drugmaker
4 weeks ago
Deals
China
Help us find 2025's best biotech startups: Nominations are open for Endpoints 11
4 weeks ago
Startups
Editor's note
Updated: Sage's roller coaster ends in $561M acquisition by Supernus
4 weeks ago
Deals
Lilly posts encouraging early-stage weight loss data on amylin candidate
4 weeks ago
R&D
Gilead, Arcellx continue to spotlight safety of multiple myeloma cell therapy
4 weeks ago
R&D
Cell/Gene Tx
Sarepta halts Duchenne gene therapy in some patients after second death
4 weeks ago
R&D
Cell/Gene Tx
RFK removes all ACIP members, names new ones; National Resilience to close six sites; Deals and financing recap of ...
4 weeks ago
Weekly
Former CEO Anne Wojcicki wins bid for 23andMe
4 weeks ago
Deals
Health Tech
KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’
4 weeks ago
Pharma
FDA+
FDA's oncology adcomm to review GSK's Blenrep relaunch plans
4 weeks ago
Pharma
FDA+
Another round of consolidation is coming, FDA commissioner tells staff
4 weeks ago
People
FDA+
First page
Previous page
6
7
8
9
10
11
12
Next page
Last page